Evidence map›Paper›PMID 34349928›Full record

ArticleChemical science2021

An experimental approach probing the conformational transitions and energy landscape of antibodies: a glimmer of hope for reviving lost therapeutic candidates using ionic liquid.

Talia A Shmool, Laura K Martin, Liem Bui-Le, Ignacio Moya-Ramirez, Pavlos Kotidis, Richard P Matthews, Gerhard A Venter, Cleo Kontoravdi, Karen M Polizzi, Jason P Hallett

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Unveiling the Rational Development of Stimuli-Responsive Silk Fibroin-Based Ionogel Formulations.Chemistry of materials : a publication of the American Chemical Society · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Talia A ShmoolDepartment of Chemical Engineering, Imperial College London South Kensington Campus London SW7 2AZ UK j.hallett@imperial.ac.uk +44 (0)20 7594 5388.ORCID https://orcid.org/0000-0002-0415-3050
Laura K MartinDepartment of Engineering Science, University of Oxford Parks Road Oxford OX1 3PJ UK.ORCID https://orcid.org/0000-0001-7215-9633
Liem Bui-LeDepartment of Chemical Engineering, Imperial College London South Kensington Campus London SW7 2AZ UK j.hallett@imperial.ac.uk +44 (0)20 7594 5388.ORCID https://orcid.org/0000-0002-2368-1262
Ignacio Moya-RamirezDepartment of Chemical Engineering, Imperial College London South Kensington Campus London SW7 2AZ UK j.hallett@imperial.ac.uk +44 (0)20 7594 5388.ORCID https://orcid.org/0000-0001-9584-7922
Pavlos KotidisDepartment of Chemical Engineering, Imperial College London South Kensington Campus London SW7 2AZ UK j.hallett@imperial.ac.uk +44 (0)20 7594 5388.ORCID https://orcid.org/0000-0002-1384-5606
Richard P MatthewsDepartment of Chemical Engineering, Imperial College London South Kensington Campus London SW7 2AZ UK j.hallett@imperial.ac.uk +44 (0)20 7594 5388.ORCID https://orcid.org/0000-0003-3328-4954
Gerhard A VenterScientific Computing Research Unit, Department of Chemistry, University of Cape Town Rondebosch Cape Town 7701 South Africa.ORCID https://orcid.org/0000-0003-3993-1198
Cleo KontoravdiDepartment of Chemical Engineering, Imperial College London South Kensington Campus London SW7 2AZ UK j.hallett@imperial.ac.uk +44 (0)20 7594 5388.ORCID https://orcid.org/0000-0003-0213-4830
Karen M PolizziDepartment of Chemical Engineering, Imperial College London South Kensington Campus London SW7 2AZ UK j.hallett@imperial.ac.uk +44 (0)20 7594 5388.ORCID https://orcid.org/0000-0001-5435-2667
Jason P HallettDepartment of Chemical Engineering, Imperial College London South Kensington Campus London SW7 2AZ UK j.hallett@imperial.ac.uk +44 (0)20 7594 5388.ORCID https://orcid.org/0000-0003-3431-2371
Imperial College London · GBOxfam · GBUniversity of Cape Town · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding protein folding in different environmental conditions is fundamentally important for predicting protein structures and developing innovative antibody formulations. While the thermodynamics and kinetics of folding and unfolding have been extensively studied by computational methods, experimental methods for determining antibody conformational transition pathways are lacking. Motivated to fill this gap, we prepared a series of unique formulations containing a high concentration of a chimeric immunoglobin G4 (IgG4) antibody with different excipients in the presence and absence of the ionic liquid (IL) choline dihydrogen phosphate. We determined the effects of different excipients and IL on protein thermal and structural stability by performing variable temperature circular dichroism and bio-layer interferometry analyses. To further rationalise the observations of conformational changes with temperature, we carried out molecular dynamics simulations on a single antibody binding fragment from IgG4 in the different formulations, at low and high temperatures. We developed a methodology to study the conformational transitions and associated thermodynamics of biomolecules, and we showed IL-induced conformational transitions. We showed that the increased propensity for conformational change was driven by preferential binding of the dihydrogen phosphate anion to the antibody fragment. Finally, we found that a formulation containing IL with sugar, amino acids and surfactant is a promising candidate for stabilising proteins against conformational destabilisation and aggregation. We hope that ultimately, we can help in the quest to understand the molecular basis of the stability of antibodies and protein misfolding phenomena and offer new candidate formulations with the potential to revive lost therapeutic candidates.

Identifiers

PMID34349928
PMCPMC8278930
OpenAlexW3173736049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.